How Can We Manage Risks and Ensure Compliance in Bioanalytical Testing?
Key Insights:
- Explore high-resolution mass spectrometry for DART and IND studies.
- Minimize sources of variability to overcome matrix effects.
- Optimize calibration accuracy to enhance drug safety and efficacy.
- Address challenges unique to biotherapeutic development.
- Maximize resources by predicting toxicity earlier in development.